Research Topics
| Daniel J SaferSummaryAffiliation: Johns Hopkins University Country: USA Publications
|
Detail Information
Publications
Age-grouped differences in bipolar maniaDaniel J Safer
Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Compr Psychiatry 53:1110-7. 2012..This review of published studies compares scores on individual items of mania rating scales that systematically recorded symptom severity in persons diagnosed with bipolar disorder to identify age-grouped differences...
Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescentsDaniel J Safer
Johns Hopkins University School of Medicine, Baltimore, Maryland 21218, USA
J Child Adolesc Psychopharmacol 16:159-69. 2006..The aim of this study was to report the frequency of common treatment-emergent adverse events (AEs) from selective serotonin reuptake inhibitors (SSRIs) in children, adolescents, and adults...- Do antidepressants reduce suicide rates?D J Safer
Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Public Health 121:274-7. 2007..We conclude that available ecological evidence does not support an inverse temporal relationship between rates of completed suicide and SSRI utilization... - Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders?Daniel J Safer
Johns Hopkins University School of Medicine, Departments of Psychiatry and Pediatrics, Baltimore, Maryland, USA
Pediatrics 118:1248-51. 2006 - Age-grouped differences in adverse drug events from psychotropic medicationDaniel J Safer
Department of Psychiatry, Johns Hopkins Institutions, Baltimore, Maryland, USA
J Child Adolesc Psychopharmacol 21:299-309. 2011..This review aims to detail specific psychotropic medication treatment differences in adverse drug events (ADEs) between children, adolescents, and adults... - Mood swing and mood stabilizer: how specific are these terms?Daniel J Safer
Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Bipolar Disord 12:685-90. 2010..Within a short period of time thereafter, mood swing and mood stabilizer became very commonly used terms in psychiatry with bipolar implications... - A comparison of risperidone-induced weight gain across the age spanDaniel J Safer
Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
J Clin Psychopharmacol 24:429-36. 2004..Available data thus suggest that across the age span, youths are the most sensitive to weight gain induced by a commonly prescribed second-generation neuroleptic... - Concomitant psychotropic medication for youthsDaniel J Safer
Division of Child Psychiatry, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Am J Psychiatry 160:438-49. 2003..This study reviewed the clinical research and practice literature relating to the prevalence and patterns of concomitant psychotropic medication given to youths with emotional and behavioral disorders... - Stimulant treatment in Maryland public schoolsD J Safer
Departments of Psychiatry and Pediatrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Pediatrics 106:533-9. 2000.... - Pemoline hepatotoxicity and postmarketing surveillanceD J Safer
Division of Child Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Am Acad Child Adolesc Psychiatry 40:622-9. 2001..S. Food and Drug Administration (FDA) between 1975 and 1996 and to describe the medical community's lack of awareness of these reports... - Psychotropic medication patterns among youth in foster careJulie M Zito
Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA
Pediatrics 121:e157-63. 2008..Systematic data on patterns of medication treatment, particularly concomitant drugs, for youth in foster care are limited... - Antidepressant prevalence for youths: a multi-national comparisonJulie M Zito
University of Maryland, Baltimore, MD 21201, USA
Pharmacoepidemiol Drug Saf 15:793-8. 2006..To compare antidepressant prevalence data in youths across three western European countries (Denmark, Germany, and the Netherlands) with US regional data in terms of age and gender and to show proportional subclass antidepressant (ATD) use... - Impact of the 2004 Food and Drug Administration pediatric suicidality warning on antidepressant and psychotherapy treatment for new-onset depressionSatish Valluri
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA
Med Care 48:947-54. 2010..To assess the national impact of the March 2004 Food and Drug Administration (FDA) antidepressant suicidality warning on the outpatient treatment of new-onset depression in youth... - Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youthsJulie Magno Zito
University of Maryland, Baltimore, 515 West Lombard Street, Baltimore, Maryland 21201, USA
Psychiatr Serv 56:157-63. 2005..This study sought to determine the degree to which Medicaid eligibility categories modify disparities between black and white youths in the prevalence of psychotropic medication... - Psychotropic practice patterns for youth: a 10-year perspectiveJulie Magno Zito
Department of Pharmacy Practice and Science, University of Maryland, 100 Greene St, Room 5 13, Baltimore, MD 21201, USA
Arch Pediatr Adolesc Med 157:17-25. 2003..To examine changes in the full spectrum of psychotropic medication treatment for youths from 1987 to 1996... - Psychotherapeutic medication prevalence in Medicaid-insured preschoolersJulie M Zito
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
J Child Adolesc Psychopharmacol 17:195-203. 2007..To update knowledge of the prevalence of the use of psychotherapeutic medications in preschoolers with Medicaid insurance as requested by the Best Pharmaceuticals for Children Act of 2002 (BPCA)... - Multiple psychotropic medication use for youths: a two-state comparisonSusan dosReis
Johns Hopkins Medicine, Division of Child and Adolescent Psychiatry, Baltimore, MD 21287, USA
J Child Adolesc Psychopharmacol 15:68-77. 2005..The aim of this study was to compare multiple psychotropic use among youths enrolled in two U.S. mid-Atlantic state Medicaid and state Children's Health Insurance Programs (SCHIP)... - Rising prevalence of antidepressants among US youthsJulie Magno Zito
School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
Pediatrics 109:721-7. 2002..To examine changes in antidepressant (ATD) prevalence and the sociodemographic and clinical correlates of ATD use among youths who are treated in community practice settings... - Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youthsDaniel J Safer
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA
Psychiatr Serv 55:1049-51. 2004..These administrative differences may partly explain the comparatively higher rate of psychotropic use under the SCHIP... - Is there a connection between methylphenidate and cancer in youth?Julie Magno Zito
University of Maryland, Pharmaceutical Health, 220 Arch St, Baltimore, Maryland, USA
Pharmacoepidemiol Drug Saf 16:1273-4. 2007 - Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorderSusan dosReis
Division of Child and Adolescent Psychiatry, School of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
J Dev Behav Pediatr 24:155-62. 2003..The findings highlight parental misconceptions and reservations about ADHD medication treatment that require clarification as to whether race/ethnicity, income, and social status influence their views and use of treatments... 
Mental health services for youths in foster care and disabled youthsS dosReis
School of Pharmacy, University of Maryland, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD, USA
Am J Public Health 91:1094-9. 2001..This study assessed whether mental health services for youths differ with respect to medical assistance aid category...- Design and reporting modifications in industry-sponsored comparative psychopharmacology trialsDaniel J Safer
Departments of Psychiatry and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, 7702 Dunmanway, Dundalk, MD 21222, USA
J Nerv Ment Dis 190:583-92. 2002.... - Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorderJ M Zito
Department of Pharmacy Practice and Science, School of Pharmacy, University of Maryland, Baltimore, USA
Arch Pediatr Adolesc Med 153:1257-63. 1999.... - Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decadeJulie Magno Zito
Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, MD 21201, USA
Psychiatr Serv 64:223-9. 2013..This cross-sectional study evaluated the impact of Medicaid-eligibility category on the increased use of antipsychotic medication by Medicaid-insured youths across a decade... - National trends in pediatric use of anticonvulsantsAllen R Tran
Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
Psychiatr Serv 63:1095-101. 2012..This research study aimed to assess national trends in pediatric use of anticonvulsants for seizures and psychiatric disorders... - Anticonvulsant treatment for psychiatric and seizure indications among youthsJulie Magno Zito
Department of Pharmaceutical Health Services Research, University of Maryland in Baltimore, MD 21201, USA
Psychiatr Serv 57:681-5. 2006..This study compared the prevalence of anticonvulsant treatment for youths with a diagnosis of a psychiatric disorder to youths with a diagnosis of a seizure disorder...